CA2566166A1 - Flavonols ameliores - Google Patents

Flavonols ameliores Download PDF

Info

Publication number
CA2566166A1
CA2566166A1 CA 2566166 CA2566166A CA2566166A1 CA 2566166 A1 CA2566166 A1 CA 2566166A1 CA 2566166 CA2566166 CA 2566166 CA 2566166 A CA2566166 A CA 2566166A CA 2566166 A1 CA2566166 A1 CA 2566166A1
Authority
CA
Canada
Prior art keywords
group
compound
formula
alkyl
heterocycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2566166
Other languages
English (en)
Other versions
CA2566166C (fr
Inventor
Spencer John Williams
Owen Llewellyn Woodman
Suwan Yap
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
YAP SU WAN
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA2566166A priority Critical patent/CA2566166C/fr
Publication of CA2566166A1 publication Critical patent/CA2566166A1/fr
Application granted granted Critical
Publication of CA2566166C publication Critical patent/CA2566166C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2566166A 2006-10-30 2006-10-30 Flavonols ameliores Expired - Fee Related CA2566166C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2566166A CA2566166C (fr) 2006-10-30 2006-10-30 Flavonols ameliores

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2566166A CA2566166C (fr) 2006-10-30 2006-10-30 Flavonols ameliores

Publications (2)

Publication Number Publication Date
CA2566166A1 true CA2566166A1 (fr) 2008-04-30
CA2566166C CA2566166C (fr) 2013-12-03

Family

ID=39367028

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2566166A Expired - Fee Related CA2566166C (fr) 2006-10-30 2006-10-30 Flavonols ameliores

Country Status (1)

Country Link
CA (1) CA2566166C (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101838252A (zh) * 2010-05-27 2010-09-22 北京德众万全医药科技有限公司 2-正丁基-5-取代氨基苯并呋喃及其制备方法
WO2012049460A1 (fr) * 2010-10-13 2012-04-19 Antoxis Limited Composé

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101838252A (zh) * 2010-05-27 2010-09-22 北京德众万全医药科技有限公司 2-正丁基-5-取代氨基苯并呋喃及其制备方法
WO2012049460A1 (fr) * 2010-10-13 2012-04-19 Antoxis Limited Composé
US9359323B2 (en) 2010-10-13 2016-06-07 Donald Barton McPhail Compound

Also Published As

Publication number Publication date
CA2566166C (fr) 2013-12-03

Similar Documents

Publication Publication Date Title
Fu et al. New chalcone derivatives: synthesis, antiviral activity and mechanism of action
Cao et al. Synthesis, acute toxicities, and antitumor effects of novel 9-substituted β-carboline derivatives
CN106928206B (zh) 醛基类化合物及其制法和用途
Liu et al. Synthesis of a novel series of diphenolic chromone derivatives as inhibitors of NO production in LPS-activated RAW264. 7 macrophages
US7863323B1 (en) Flavonols
CZ413491A3 (en) N-imidazolyl derivatives of bicyclic compounds and process for preparing thereof
EP2526941A1 (fr) Modalités anti-inflammatoires
Yang et al. l-Proline catalyzed three-component synthesis of para-naphthoquinone–4-aza-podophyllotoxin hybrids as potent antitumor agents
KR102452412B1 (ko) 트리프톨리드의 c14-히드록실 에스테르화 아미노산 유도체, 및 그의 제조 방법 및 용도
US4737517A (en) Coumarin derivatives, pharmaceutical compositions containing the same, and the use thereof in the treatment of cancer
Jin et al. Synthesis and biological evaluation of new spin-labeled derivatives of podophyllotoxin
EP0645382B1 (fr) Derive de coumarine et son utilisation
MXPA02012657A (es) Derivados de coumarina con actividad inhibidora de comt.
US8916526B2 (en) Flavanone derivative
CA2566166C (fr) Flavonols ameliores
CN109280032B (zh) 一种哒嗪酮母核结构的组蛋白去乙酰化酶抑制剂及其制备方法和用途
AU2006233256B2 (en) Improved flavonols
Lizhuo et al. Synthesis, antibacterial and antifungal evaluation of rhodanine derivatives bearing quinoxalinyl imidazole moiety as ALK5 inhibitors
KR101624344B1 (ko) 히스톤 탈아세틸화 효소 억제 활성을 갖는 신규한 3-치환-2-옥소인돌린 기반 n-히드록시프로펜아미드 및 이를 유효성분으로 포함하는 항암용 조성물
Koeksal et al. Synthesis, Analgesic and Antiinflammatory properties of certain 5‐/6‐Acyl‐3‐(4‐substituted‐1‐piperazinylmethyl)‐2‐benzoxazolinones Derivatives
WO2002042309A1 (fr) Dérivés d'indole et leur utilisation dans des médicaments
Ajima et al. Synthesis, characterization and biological evaluation of benzimidazole-dihydroartemisinin hybrids as potential dual acting antimalarial agents
KR101900575B1 (ko) 신규한 히드록삼산 및 이의 용도
AU2020269125A1 (en) Substituted 3,4,12,12a-tetrahydro-1h-(1,4)oxazino(3,4-c)pyrido(2,1-f)(1,2,4)triazine-6,8-dione, pharmaceutical composition, and methods for preparing and using same
JPH0625213A (ja) フラボン誘導体

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20210831

MKLA Lapsed

Effective date: 20191030